SPEAKER	TITLE	TIME
Prof. Paolo Martelli (University Rector) Francesca Buttini (University of Parma) Cornelia Désirée Sonntag (Galenus Foundation)	Conference opening: Welcome and Introduction	9:00-9:25
NEW PARADIGMS IN LUNG DELIVERY
Keynote 1: David Edwards (Harvard University, US)	Global warming is dehydrating human airways: rehydrating with hypertonic divalent salt aerosols treats chronic cough	9:25-10:00
Michael Hindle (Virginia Commonwealth University, US)	Development of a lung surfactant powder aerosol product for babies with respiratory distress syndrome	10.00-10:25
Pavan Muttil (University of New Mexico, US)	Formulation development and preclinical evaluation of aerosol vaccines: challenges, opportunities and lessons learnt	10:25-10:50
COFFEE BREAK + POSTER SESSION
Nicola Tsapis (Paris-Saclay University, France)	Nanomedicines and microparticles for the treatment of pulmonary infections	11:30-11:55
David Cipolla (Insmed, US)	Preclinical and CMC development of treprostinil palmitil inhalation powder	11:55-12:20
Paul Hagedoorn (University of Groningen, The Netherlands)	The development of pulmonary levodopa applications for patients with Parkinson’s disease	12:20-12:45
LIGHT LUNCH + POSTER SESSION
RESPIRATORY TREE AS A SITE FOR THE DELIVERY OF BIOLOGICS
Tomaso Guidi (Chiesi Farmaceutici, Italy)	Inhaled biologics: current trends in the industry	14:30-14:55
Francesca Buttini (University of Parma, Italy)	The formulation of protein and probiotics in dry powder inhalers	14:55-15:20
Mirjam Kobler (H&T Presspart, UK)	The Sunriser – achieving high performance in challenging formulations	15:20-15:35
	To be selected from abstracts submitted	15:35-15:50
COFFEE BREAK + POSTER SESSION
Regina Scherließ (Kiel University, Germany)	Nasal vaccine technology	16:30-16:55
Ben Forbes (King’s College, London, UK)	Biologics from nose to brain	16:55-17:20
	To be selected from the abstract submitted	17:20-17:35
	To be selected from the abstract submitted	17:35-17:50
	WELCOME RECEPTION	18:00-19:30

SPEAKER	TITLE	TIME
BIOLOGICS LOVE LUNGS
Keynote 2: Hugh Smyth (University of Texas at Austin, US)	Developing inhaled mAbs and nucleic acids for therapeutic success	9:00-9:35
Jenny Lam (University College London, UK)	How to make antibodies formulation stable and inhalable	9:35-10:00
	To be selected from abstracts submitted	10:00-10:15
Simon Gardner (Bespack, UK)	Navigating the green propellant transition – strategies for the development & commercialisation of low global warming potential pMDIs	10:15-10:30
COFFEE BREAK + POSTER SESSION
ENVIRONMENTAL PROTECTION BECOMES A REALITY IN THE DEVELOPMENT OF PMDI
Paul Young (Ab Initio Pharma, AU)	TBA	11:10-11:35
Angelo Matturro (Chiesi, Italy)	Transition to LGWP propellant using HFA152a	11:35-11:50
David Lechuga (Astra Zeneca, US)	pMDI engineered particle suspensions in next generation propellants	11:50-12:15
Chris Baron (Aptar Pharma, France)	Key learnings and pathways forward. Circumnavigating the challenges of your low GWP pMDI transition programs	12:15-12:30
Sergio Monti (RxPack Italy)	Shifting tides: pMDI market scenarios into the low GWP propellant transition	12:30-12:45
LIGHT LUNCH + POSTER SESSION
LAST FRONTIERS IN LUNG INFECTION
Keertan Dheda (University of Cape Town, South Africa)	Challenges in the prevention and management of drug-sensitive and drug-resistant Tuberculosis	14:15-14:40
Lea Ann Dailey (University of Vienna, Austria)	A liposomal strategy for inhaled bedaquiline: in vivo pharmacodynamics and pharmacokinetics	14:40-15:05
Francesca Ungaro (University of Naples, Italy)	Novel formulation approaches for lung infection treatment	15:05-15:30
COFFEE BREAK + POSTER SESSION
PhD Students Contest Seven7th	Seven talks of 7 minutes selected from abstract submission	16:00-17:15

SPEAKER	TITLE	TIME
NEW RESEARCH
Federico Lavorini (University of Florence, Italy)	Physiological and technological barriers in the treatment of COPD	9:15-9:40
Jan de Backer (FLUIDDA, US)	The role of digital twins and in-silico trials as regulatory tools for the authorization of orally inhaled drugs	9:40-10:05
Carsten Ehrhardt (Trinity College, Ireland)	Uptake mechanisms of molecules released into the lungs	10:05-10:30
Yannick Baschung (Solvias AG, Germany)	Enhancing respiratory therapy with digital inhalers: Insights from multi-modal experimental and In-Vitro analysis	10:30-10:45
COFFEE BREAK + POSTER SESSION
Daniela Traini & Julie Suman (Macquarie University, Australia & Aptar, US )	Non-clinical tests in the evaluation of inhaled pharmaceuticals	11:15-11:40
Per Bäckmann (Emmace, Sweden)	Physiologically-based biopharmaceutical models- a tool to understand local and systemic exposure of inhaled medicines	11:40-12:05
Sharareh Salar-Behzadi (RCPE, Austria)	Lipid-Based Drug Delivery for Inhaled Therapeutics	12:05-12:30
Noémi Stefánia Csaba (University of Santiago de Compostela, Spain)	A multi-stage pulmonary drug delivery system based on sporopollenin	12:30-12:55
Francesca Buttini	CLOSING REMARKS	12:55-13:00

Prof. Paolo Martelli (University Rector), Francesca Buttini (University of Parma), Cornelia Désirée Sonntag (Galenus Foundation)
Conference Opening: Welcome and Introduction     
9:00-9:25

 

NEW PARADIGMS IN LUNG DELIVERY

Keynote 1: David Edwards (Harvard University, US)
Global warming is dehydrating human airways: rehydrating with hypertonic divalent salt aerosols treats chronic cough
9:25-10:00  

 

Michael Hindle (Virginia Commonwealth University, US)
Development of a Lung Surfactant Powder Aerosol Product for Babies with Respiratory Distress Syndrome
10:00-10:25  

 

Pavan Muttil (University of New Mexico, US)
Formulation Development and Preclinical Evaluation of Aerosol Vaccines: Challenges, Opportunities and Lessons Learnt
10:25-10:50

 

COFFEE BREAK + POSTER SESSION  

 

Nicola Tsapis (Paris-Saclay University, France)
Nanomedicines and microparticles for the treatment of pulmonary infections
11:30-11:55  

 

David Cipolla (Insmed, US)
Preclinical and CMC Development of Treprostinil Palmitil Inhalation Powder (IPF)
11:55-12:20  

 

Paul Hagedoorn (University of Groningen, The Netherlands)
The development of pulmonary levodopa applications for patients with Parkinson’s disease
12:20-12:45

 

LIGHT LUNCH + POSTER SESSION  

 

RESPIRATORY TREE AS A SITE FOR THE DELIVERY OF BIOLOGICS

Tomaso Guidi (Chiesi Farmaceutici , Italy)
Inhaled Biologics: current trends in the industry
14:30-14:55  

 

Francesca Buttini (University of Parma, Italy)
The formulation of protein and probiotics in dry powder inhalers
14:55-15:20  

 

Mirjam Kobler (H&T Presspart, UK)
The Sunriser – achieving high performance in challenging formulations
15:20-15:35  

 

To be selected from abstracts submitted
15:35-15:50

 

COFFEE BREAK + POSTER SESSION 

 

Regina Scherließ (Kiel University, Germany)
Nasal vaccine technology
16:30-16:55  

 

Ben Forbes (King’s College, London, UK)
Biologics from nose to brain
16:55-17:20  

 

To be selected from the abstract submitted
17:20-17:35

 

To be selected from the abstract submitted
17:35-17:50

 

WELCOME RECEPTION

18:00-19:30

BIOLOGICS LOVE LUNGS

Keynote 2: Hugh Smyth (University of Texas at Austin, US)
Developing inhaled mAbs and nucleic acids for therapeutic success
9:00-9:35

 

Jenny Lam (University College London, UK)
How to make antibodies formulation stable and inhalable
9:35-10:00

 

To be selected from abstracts submitted
10:00-10:15

 

Simon Gardner (Bespack, UK)
Navigating the green propellant transition – strategies for the development & commercialisation of low global warming potential pMDIs
10:15-10:30

 

COFFEE BREAK + POSTER SESSION  

 

ENVIRONMENTAL PROTECTION BECOMES A REALITY IN THE DEVELOPMENT OF PMDI

Paul Young (Ab Initio Pharma, AU)
TBA
11:10-11:35  

 

Angelo Matturro (Chiesi, Italy)
Transition to LGWP propellant using HFA152a
11:35-11:50

 

David Lechuga (Astra Zeneca, US)
pMDI engineered particle suspensions in next generation propellants
11:50-12:15  

 

Chris Baron (Aptar Pharma, France)
Key learnings and pathways forward. Circumnavigating the challenges of your low GWP pMDI transition programs
12:15-12:30

 

Sergio Monti (RxPack Italy)
Shifting tides: pMDI market scenarios into the low GWP propellant transition
12:30-12:45

 

LIGHT LUNCH + POSTER SESSION  

 

 

LAST FRONTIERS IN LUNG INFECTION

Keertan Dheda (University of Cape Town, South Africa)
Challenges in the prevention and management of drug-sensitive and drug-resistant Tuberculosis
14:15-14:40

 

Lea Ann Dailey (University of Vienna, Austria)
A liposomal strategy for inhaled bedaquiline: in vivo pharmacodynamics and pharmacokinetics
14:40-15:05

 

Francesca Ungaro (University of Naples, Italy)
Novel formulation approaches for lung infection treatment
15:05-15:30

 

LIGHT LUNCH + POSTER SESSION    

PhD Students Contest Seven7th
Seven talks of 7 minutes selected from abstract submission
16:00-17:15

NEW RESEARCH

Federico Lavorini (University of Florence, Italy)
Physiological and Technological barriers in the treatment of COPD
9:15-9:40

 

Jan de Backer (FLUIDDA, US)
The role of digital twins and in-silico trials as regulatory tools for the authorization of orally inhaled drugs
9:40-10:05

 

Carsten Ehrhardt (Trinity College, Ireland)
Uptake mechanisms of molecules released into the lungs
10:05-10:30 

 

Yannick Baschung (Solvias AG, Germany)
Enhancing respiratory therapy with digital inhalers: Insights from multi-modal experimental and In-Vitro analysis
10:30-10:45

 

COFFEE BREAK + POSTER SESSION  

 

Daniela Traini & Julie Suman  (Macquarie University, Australia & Aptar, US)
Non-Clinical Tests in the Evaluation of Inhaled Pharmaceuticals
11:15-11:40

 

Per Backmann (Emmace, Sweden)
Physiologically-based biopharmaceutical models- a tool to understand local and systemic exposure of inhaled medicines
11:40-12:05

 

Sharareh Salar-Behzadi (RCPE, Austria)
Lipid-Based Drug Delivery for Inhaled Therapeutics
12:05-12:30

 

Noémi Stefánia Csaba (University of Santiago de Compostela, Spain)
A multi-stage pulmonary drug delivery system based on sporopollenin
12:30-12:55

 

Francesca Buttini
CLOSING REMARKS
12:55-13.00